FI89491B - Analogifoerfarande foer framstaellning av farmakologiskt vaerdefulla 5-halogentienoisotiazol-3(2H)-on-1,1-dioxider - Google Patents

Analogifoerfarande foer framstaellning av farmakologiskt vaerdefulla 5-halogentienoisotiazol-3(2H)-on-1,1-dioxider Download PDF

Info

Publication number
FI89491B
FI89491B FI890690A FI890690A FI89491B FI 89491 B FI89491 B FI 89491B FI 890690 A FI890690 A FI 890690A FI 890690 A FI890690 A FI 890690A FI 89491 B FI89491 B FI 89491B
Authority
FI
Finland
Prior art keywords
formula
dioxide
compounds
compound
acid
Prior art date
Application number
FI890690A
Other languages
English (en)
Finnish (fi)
Other versions
FI890690A0 (fi
FI890690A (fi
FI89491C (sv
Inventor
Dieter Binder
Franz Rovenszky
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of FI890690A0 publication Critical patent/FI890690A0/fi
Publication of FI890690A publication Critical patent/FI890690A/fi
Publication of FI89491B publication Critical patent/FI89491B/fi
Application granted granted Critical
Publication of FI89491C publication Critical patent/FI89491C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Claims (2)

1. Förfarande för framställning av farmakologiskt värdeful-la 5-halogentienoisotiazol-3(2H)-on-1,1-dioxider med for-5 me1n (I ) 0 0 10 “2— (α'2,η~·'( R’ 5 li där är väte, (-C^)-a 1 ky1 eller halogen,
15 R2 är halogen och n är ett heltal 2-6, samt deras farmaceutiskt godtagbara syraadditionssalter, kännetecknat därav, att en förening med formeln (II) 20 O 0 \\ / /^Υ*\ *2—\ » - - X 25 \ 0 där R2 och n är säsom ovan definierats och X avser halogen, omsätts i ett organiskt utspädningsmedel 30 och vid 20 - 150°C med en förening med formeln (III) /-\ N λ HN V— ^ \-R1 m 35 ^-' *=* I: 17 89491 där är ovan definierad, och den sa erhällna basen med for-meln (I) omvandlas vid behov tili ett farmaceutiskt god-tagbart syraadditionssalt. 5
2. Förfarande enligt patentkravet 1, känneteck-n a t därav, att 5-klor-2-(4-(4-(2-pyrimidiny1)-1-pipera-zinyl) butyl)tieno(2,3-d)isotiazol-3(2H)-on-l,l-dioxid f ramstä11 s. 10
FI890690A 1988-02-18 1989-02-14 Analogiförfarande för framställning av farmakologiskt värdefulla 5-hal ogentienoisotiazol-3(2H)-on-1,1-dioxider FI89491C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT88390A ATA39088A (de) 1988-02-18 1988-02-18 Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung
AT39088 1988-02-18

Publications (4)

Publication Number Publication Date
FI890690A0 FI890690A0 (fi) 1989-02-14
FI890690A FI890690A (fi) 1989-08-19
FI89491B true FI89491B (fi) 1993-06-30
FI89491C FI89491C (sv) 1993-10-11

Family

ID=3489327

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890690A FI89491C (sv) 1988-02-18 1989-02-14 Analogiförfarande för framställning av farmakologiskt värdefulla 5-hal ogentienoisotiazol-3(2H)-on-1,1-dioxider

Country Status (28)

Country Link
US (1) US4929616A (sv)
EP (1) EP0328913B1 (sv)
JP (1) JPH01249779A (sv)
KR (1) KR890013033A (sv)
CN (1) CN1024798C (sv)
AT (2) ATA39088A (sv)
AU (1) AU618577B2 (sv)
CA (1) CA1317956C (sv)
CS (1) CS274578B2 (sv)
DD (1) DD279021A5 (sv)
DE (1) DE58907804D1 (sv)
DK (1) DK170047B1 (sv)
EG (1) EG20261A (sv)
ES (1) ES2054887T3 (sv)
FI (1) FI89491C (sv)
HR (1) HRP940825A2 (sv)
HU (1) HU201084B (sv)
IL (1) IL89185A (sv)
LT (1) LT3947B (sv)
MY (1) MY103825A (sv)
NO (1) NO176050C (sv)
NZ (1) NZ227939A (sv)
PH (1) PH26156A (sv)
SI (1) SI8910358A (sv)
SU (1) SU1729293A3 (sv)
UA (1) UA13481A (sv)
YU (1) YU35889A (sv)
ZA (1) ZA891108B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0376633B1 (en) * 1988-12-28 1994-10-12 Suntory Limited Benzoxazepine derivatives
CA2567813C (en) 2004-05-23 2015-11-24 Gerard M. Housey Theramutein modulators
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
CN103789389B (zh) * 2005-11-23 2017-01-04 杰勒德·M·豪斯 鉴定、合成、优化和表征蛋白调节剂的化合物和方法
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用
US8551560B2 (en) * 2008-05-23 2013-10-08 Intermolecular, Inc. Methods for improving selectivity of electroless deposition processes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47877A (en) 1974-08-26 1978-10-31 Sparamedica Ag Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
DE2534689B2 (de) 1974-09-16 1979-03-01 Basf Ag, 6700 Ludwigshafen 23-Dihydro-3-oxo-thieno-isothiazol-1,1-dioxide
LU78009A1 (de) 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE2749640A1 (de) 1977-11-05 1979-05-10 Thomae Gmbh Dr K Ein thieno eckige klammer auf 3,2-d eckige klammer zu isothiazolondioxid, verfahren zu seiner herstellung und dessen verwendung
AT364852B (de) * 1977-11-05 1981-11-25 Thomae Gmbh Dr K Verfahren zur herstellung von kondensierten isothiazol-3(2h)-on-1,1-dioxiden und von deren salzen
DE2839266A1 (de) 1978-09-09 1980-03-20 Thomae Gmbh Dr K Kondensierte isothiazol-3(2h)-on-1,1- dioxide, verfahren zu deren herstellung und deren verwendung
ATE26720T1 (de) 1982-09-09 1987-05-15 Hoffmann La Roche Thieno(2,3-e)-1,2-thiazin-derivate.
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
FI862513A (fi) * 1985-07-04 1987-01-05 Chemie Linz Ag Nya tieno-1,2-tiazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
US4675403A (en) * 1985-10-16 1987-06-23 American Home Products Corporation 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity
US4732984A (en) * 1985-10-17 1988-03-22 American Home Products Corporation Piperazinoisothiazolones with psychotropic activity

Also Published As

Publication number Publication date
CN1024798C (zh) 1994-06-01
CS274578B2 (en) 1991-08-13
AU2994589A (en) 1989-08-24
PH26156A (en) 1992-03-18
ATA39088A (de) 1990-06-15
IL89185A (en) 1992-08-18
DD279021A5 (de) 1990-05-23
NZ227939A (en) 1991-02-26
EP0328913A2 (de) 1989-08-23
HUT50839A (en) 1990-03-28
FI890690A0 (fi) 1989-02-14
DK170047B1 (da) 1995-05-08
DK73289A (da) 1989-10-11
SI8910358A (sl) 1997-02-28
FI890690A (fi) 1989-08-19
CA1317956C (en) 1993-05-18
KR890013033A (ko) 1989-09-21
SU1729293A3 (ru) 1992-04-23
NO890691D0 (no) 1989-02-17
JPH01249779A (ja) 1989-10-05
UA13481A (uk) 1997-04-25
LT3947B (en) 1996-05-27
ATE106888T1 (de) 1994-06-15
CS93189A2 (en) 1990-10-12
HRP940825A2 (en) 1996-04-30
DE58907804D1 (de) 1994-07-14
EP0328913B1 (de) 1994-06-08
LTIP1813A (en) 1995-08-25
YU35889A (en) 1990-06-30
NO176050C (no) 1995-01-25
CN1038646A (zh) 1990-01-10
AU618577B2 (en) 1992-01-02
EP0328913A3 (de) 1991-01-23
ES2054887T3 (es) 1994-08-16
MY103825A (en) 1993-09-30
NO176050B (no) 1994-10-17
ZA891108B (en) 1989-10-25
NO890691L (no) 1989-08-21
DK73289D0 (da) 1989-02-17
FI89491C (sv) 1993-10-11
EG20261A (en) 1998-05-31
HU201084B (en) 1990-09-28
IL89185A0 (en) 1989-09-10
US4929616A (en) 1990-05-29

Similar Documents

Publication Publication Date Title
CS202515B2 (en) Method of producing novel 4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxides
AU7451298A (en) Novel cyclic diamine compounds and medicine containing the same
CZ87793A3 (en) Process for preparing arylpiperazinyl heterocyclic compounds
PL85278B1 (sv)
IE920734A1 (en) 4-aryl-thiazole or imidazole derivatives
FI64144C (fi) Foerfarande foer framstaellning av 2-arylamino-2-imidazolinderivat
FI89491C (sv) Analogiförfarande för framställning av farmakologiskt värdefulla 5-hal ogentienoisotiazol-3(2H)-on-1,1-dioxider
NZ573352A (en) Substituted carboxamides as group i metabotropic receptor antagonists
US20040038987A1 (en) Novel cyclic diamine compounds and medicine containing the same
US5026717A (en) 2-imino-6-polyfluoroalkoxybenzothiazole derivatives, and pharmaceutical compositions containing them
FI89267B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 4,5-dihydro-oxazoler
CA2624383C (en) Salts of modulators of ppar and methods of treating metabolic disorders
CS259516B2 (en) Method of new heterocyclic compounds production
US4082757A (en) Amides of 4-hydroxy-6H-thieno[2,3-b]thiopyran-5-carboxylic acid-7,7-dioxide
US3853872A (en) 2,3,4,5-substituted thiazoles
Keshari et al. Novel Mannich-bases as potential anticonvulsants: syntheses, characterization and biological evaluation
EP0009142A1 (de) Neue 4-Hydroxy-2H(1)benzothieno(2,3-e)-1,2-thiazin-3-carboxamid-1,1-dioxide sowie deren Salze, deren Verwendung und Verfahren zu ihrer Herstellung
CS272769B2 (en) Method of pyridazopyridone's new tricyclic derivatives production
JPS61205275A (ja) 新規の8‐チオテトラヒドロキノリン誘導体及びそれらの塩
Wright et al. (2-Carboxy-1, 4-dihydro-4-oxoquinolyl) oxamic acids and (2-carboxy-1, 4-dihydro-4-oxobenzo [h] quinolyl) oxamic acids as antiallergy agents
US4282225A (en) Thiazole derivatives useful in therapy as anti-depressant agents
FR2571723A1 (fr) Derives de thieno et furo-(2,3-c) pyrroles, procedes de preparation et medicaments les contenant
JPH06135925A (ja) ヒスタミンh▲2▼−受容体拮抗活性をもつ置換3,4−ジアミノ−1,2,5−チアジアゾール用中間体
JPH0495071A (ja) カルバミン酸誘導体
PL118018B1 (en) Process for preparing novel 2,6-bis/aminoacyloamino/-benzo/1,2-d:5,4-d'/-bisthiazoles and 2-amino-6-/aminoacyloamino/-benzo/1,2-d:5,4-d'/-bisthiazoleseh:5,4-deh/-bistiazolejj i 2-amino-6-/aminoaciloamino/-benzo/1,2-deh:5,4-deh/bistiazolejj

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: CHEMISCH PHARMAZEUTISCHE